Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Knoll Mavik

Executive Summary

Knoll Mavik: ACE inhibitor trandolapril gains new indication for use in stable patients who have evidence of left-ventricular systolic dysfunction or who are symptomatic from congestive heart failure within the first few days after sustaining acute myocardial infarction. The recommended starting dose for the indication is 1 mg once daily, with titration to a target dose of 4 mg once daily...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030546

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel